Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Treasury Shares (2016 - 2025)

Cytosorbents' Treasury Shares history spans 10 years, with the latest figure at $775301.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $775301.0 for Q4 2025, up 20.89% from a year ago — trailing twelve months through Dec 2025 was $775301.0 (up 20.89% YoY), and the annual figure for FY2025 was $775301.0, up 20.89%.
  • Treasury Shares for Q4 2025 was $775301.0 at Cytosorbents, down from $2.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.8 million in Q3 2025 to a low of $125340.0 in Q2 2022.
  • The 5-year median for Treasury Shares is $387376.0 (2021), against an average of $885413.8.
  • The sharpest move saw Treasury Shares soared 804.7% in 2023, then tumbled 77.29% in 2024.
  • Year by year, Treasury Shares stood at $304962.0 in 2021, then rose by 2.34% to $312092.0 in 2022, then soared by 804.7% to $2.8 million in 2023, then tumbled by 77.29% to $641336.0 in 2024, then increased by 20.89% to $775301.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $775301.0, $2.8 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.